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Abstract
Background: Transcutaneous in vivo electroporation is expected to be an effective gene-transfer
method for promoting bone regeneration using the BMP-2 plasmid vector. To promote enhanced
osteoinduction using this method, we simultaneously transferred cDNAs for BMP-2 and BMP-7, as
inserts in the non-viral vector pCAGGS.
Methods: First, an in vitro study was carried out to confirm the expression of BMP-2 and BMP-7
following the double-gene transfer. Next, the individual BMP-2 and BMP-7 plasmids or both
together were injected into rat calf muscles, and transcutaneous electroporation was applied 8
times at 100 V, 50 msec.
Results: In the culture system, the simultaneous transfer of the BMP-2 and BMP-7 genes led to a
much higher ALP activity in C2C12 cells than did the transfer of either gene alone. In vivo, ten days
after the treatment, soft X-ray analysis showed that muscles that received both pCAGGS-BMP-2
and pCAGGS-BMP-7 had better-defined opacities than those receiving a single gene. Histological
examination showed advanced ossification in calf muscles that received the double-gene transfer.
BMP-4 mRNA was also expressed, and RT-PCR showed that its level increased for 3 days in a time-
dependent manner in the double-gene transfer group. Immunohistochemistry confirmed that BMP-
4-expressing cells resided in the matrix between muscle fibers.
Conclusion: The simultaneous transfer of BMP-2 and BMP-7 genes using in vivo electroporation
induces more rapid bone formation than the transfer of either gene alone, and the increased
expression of endogenous BMP-4 suggests that the rapid ossification is related to the induction of
BMP-4.
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Background
Non-viral gene delivery systems are potentially useful in
gene therapies for tissue regeneration or repair [1,2]. In
particular, electroporation is attractive, because it is an
easy and inexpensive method that requires only a plasmid
and a device for performing electroporation [3,4]. In addi-
tion, the method does not require viral vectors, expensive
proteins, or carrier matrices. Previously, we constructed a
human BMP-2 gene expression vector (pCAGGS-BMP-2)
and showed that transferring the BMP-2 gene into rat skel-
etal muscles by in vivo transcutaneous electroporation
induced ectopic bone formation [5]. However, there was
no significant relationship between the dose of pCAGGS-
BMP-2 plasmid vector used and the volume, quality, or
time course of the ectopic bone formation. In this model,
the surface area the electrodes can cover restricts the vol-
ume of the injected plasmid to 50 μl. Furthermore, any
interaction between the plasmid dose and the electrical
parameters can affect the efficiency of the gene transfer
[6]. For clinical applications, it is important to optimize
the method to enhance bone formation at the level of the
intrinsic osteoinductive activity.
Comparative analyses of the osteogenic activity of various
human BMP adenoviral vectors have indicated that each
BMP has a different potential to induce bone formation
[7,8]. In culture, protein purified from the supernatant of
adenoviral vector-infected epithelial cells expressing both
BMP-2 and BMP-7 accelerates the differentiation of pre-
osteoblastic or premyogenic cells into osteoblastic cells
[9]. In addition, culture supernatant from CHO cells that
were transiently transfected with equal amounts of BMP-
2 and BMP-7 expression vectors induces maximal alkaline
phosphatase (ALP) activity in a mouse stromal cell culture
system [10]. These researchers concluded that the com-
bined transfer of the BMP-2 and BMP-7 genes to epithelial
cells such as CHO or 293 cells produces the heterodimer
BMP-2/7, and that it is the BMP-2/7 in the supernatant
that enhances the differentiation of the preosteoblastic or
myoblastic cells into osteogenic cells, leading to osteoin-
duction [9,10]. However, there are few reports of the effect
on bone formation of the simultaneous and direct gene
transfer of two or more BMPs. The present study was
undertaken to determine whether the combined gene
transfer of BMP-2 and BMP-7 into skeletal muscles in rats
using in vivo electroporation could induce ectopic bone
formation more rapidly than the transfer of only one of
these genes. In addition, the endogenous BMP-4 mRNA
expression levels and BMP-4-expressing cells were exam-
ined, since several reports show that exogenous BMPs ele-
vate the levels of other BMPs or BMP-4 mRNA [11-14].
Prior to the in vivo study mentioned above, the effect of
the combined direct gene transfer of BMP-2 and BMP-7
into myoblastic cells was also assessed using an in vitro
gene-transfer system.
Methods
Plasmid vector
Human BMP-7 cDNA was obtained by PCR with pUC
BMP-7 as the template and the following primers: human
BMP-7 forward primer, 5'-GAG AGA GAG AAGCTT GGA
TCC ATG GTG GCC GGG ACC CGC (ATG, initial codon);
human BMP-7 backward primer, 5'-AGA GAG AG
AAGCTT CTA GTG GCA GCC ACA GGC CCG GAC CA
(CTA, stop codon). Both primers had SwaI recognition
sites (italicized). The PCR protocol consisted of 25 cycles
of 15 sec at 98°C, 2 sec at 65°C, and 30 sec at 74°C, with
KOD DNA polymerase (ToYoBo, Osaka, Japan). The PCR
product was blunt-ended and ligated into the EcoRI-
digested and blunt-ended cloning site of the pCAGGS
expression vector, which contains the CAG (cytomegalo-
virus immediate-early enhancer/chicken β-actin hybrid)
promoter [15], to yield pCAGGS-BMP-7. The 1296-bp
insert sequence was confirmed by DNA sequencing.
PCAGGS-BMP-2 was described previously [5]. Plasmids
were grown in Escherichia coli DH5α. Plasmid vectors were
prepared using a Qiagen EndoFree plasmid Giga kit (Qia-
gen GmbH, Hilden, Germany), as described previously
[4].
ALP activity in C2C12 cells
We investigated the activity of ALP, which is a marker for
osteoblastic differentiation, in C2C12 cells, a mouse
myoblastic cell line, by directly and simultaneously trans-
fecting them with equal doses of pCAGGS-BMP-2 and
pCAGGS-BMP-7. The cells were cultured at 1 × 105 cells
per well in 12-well plates in 1 ml growth medium
(DMEM, 15% fetal bovine serum) for 1 day before the
transfection. The next day, 0.5 μg pCAGGS and 0.5 μg
pCAGGS-BMP-2, 0.5 μg pCAGGS and 0.5 μg pCAGGS-
BMP-7, or 0.5 μg pCAGGS-BMP-2 and 0.5 μg pCAGGS-
BMP-7 were diluted in 100 μl Opti-MEM (Invitrogen, Cal-
ifornia, USA), then mixed with 4.0 μl Lipofectamine 2000
(Invitrogen, California, USA) in 100 μl Opti-MEM. These
DNA-lipofectamine 2000 complexes were added to each
well of 90% confluent C2C12 cells. One day after the
transfection, the medium was changed. At 10 days after
the transfection, the cells were rinsed with phosphate
buffered saline (PBS), and the cells from two 12-well
plates were collected. The cells were lysed with 1 M Tris-
HCl (pH 7.4), 5 M NaCl, 0.5 M EDTA, 0.5 M NaF, and
10% Nonident P-40. The lysates were spun and the super-
natant collected. The quantitative ALP activity data and
total protein content of the supernatants were determined
by the p-nitrophenyl phosphate method. One 12-well
plate was used for the histochemical staining of ALP, per-
formed using a Sigma diagnostic ALP kit (Sigma, St. Louis,
MO).BMC Musculoskeletal Disorders 2006, 7:62 http://www.biomedcentral.com/1471-2474/7/62
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Animals
Nine-week-old male Wistar rats were purchased from
Kurea (Osaka, Japan) and maintained under specific path-
ogen-free conditions in our animal facility. All procedures
were approved by the Animal Research Control Commit-
tee of Okayama University (approval No.oku-2005110).
Intramuscular DNA injection and transcutaneous 
electroporation
Rats (N = 60) were anesthetized by intraperitoneal injec-
tion of pentobarbital sodium (5.0 mg/100 g of body
weight). The fur on the target area of the leg was removed
with clippers. As shown in Fig 1, plate electrodes (Nepa
Gene, Chiba, Japan) consisting of pairs of stainless steel
plates with a fixed length of 5 mm were attached to the
skin at the target site after being coated with keratin cream
(Fukuda Denshi, Tokyo, Japan). The accuracy of the elec-
tric current applied was confirmed by measuring the
resistance (usually below 800 Ω) between the electrodes,
which surrounded the middle of the gastrocnemius mus-
cle. Next, 50 μl of plasmid DNA (total 25 μg): 12.5 μg
pCAGGS and 12.5 μg pCAGGS-BMP-2, 12.5 μg pCAGGS
and 12.5 μg pCAGGS-BMP-7, 12.5 μg pCAGGS-BMP-2
and 12.5 μg pCAGGS-BMP-7, or 25 μg pCAGGS was
injected with a 30-gauge needle into the center of the mus-
cle between the electrodes. Electroporation was started
immediately after the injection by applying 8 electrical
pulses (100 V, 50 msec): four square pulses followed by 4
more of the opposite polarity at 1-sec intervals using an
electroporator (CUY21EDIT; Nepa Gene).
Transcutaneous in vivo electroporation for skeletal muscle Figure 1
Transcutaneous in vivo electroporation for skeletal muscle. After the injection of 25 μg of plasmid into the gastrocne-
mius muscle, transcutaneous in vivo electroporation was performed via the skin of the calf to drive the gene transfer. The con-
ditions were 8 pulses of 100 V, 50 msec. *, plasmid-injected area; arrows, electrodes.BMC Musculoskeletal Disorders 2006, 7:62 http://www.biomedcentral.com/1471-2474/7/62
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Reverse transcription (RT)-PCR
Rats (each group N = 5) that had received injections of
pCAGGS and pCAGGS-BMP-2, pCAGGS and pCAGGS-
BMP-7, pCAGGS-BMP-2 and pCAGGS-BMP-7, or
pCAGGS alone were killed under general anesthesia and
the target muscles were resected (0.15 g) at 1, 3, 5, 7, and
9 days after gene transfer. Total RNA was isolated from the
targeted muscle using Isogen (Nippon Gene, Tokyo,
Japan). mRNAs for human BMP-2, human BMP-7, rat
BMP-4, and glyceraldehyde-3-phosphate dehydrogenase
(G3PDH) were detected by RT-PCR using the following
primers: human BMP-2 backward primer, 5'-TCTCTGTT-
TCAGGCCGAACA-3'; human BMP-2 forward primer, 5'-
TCTGACTGACCGCGTTACTC-3'; human BMP-7 back-
ward primer, 5'-CAAGCCCAAAATGGAGAGGA-3';
human BMP-7 forward primer, 5'-TCTGACTGACCGCGT-
TACTC-3'; rat BMP-4 backward primer, 5'-TTCTCCAGAT-
GTTCTTCGTG-3'; rat BMP-4 forward primer, 5'-
ACTGCCGCAGCTTCTCTGAG-3'; G3PDH backward
primer, 5'-TCCACCACCCTGTTGCTGTA-3'; G3PDH for-
ward primer, 5'-ACTGGCGTCTTCACCACCAT-3'. The
human BMP-2 and BMP-7 forward primers were designed
to hybridize with the sequence immediately downstream
of the transcriptional start site of the CAG promoter, so
the PCR products were not contaminated by plasmid or
genomic DNA. RNA (1 μg) was incubated at 42°C for 1 hr
in a total volume of 20 μl and then at 94°C for 3 min, fol-
lowed by 40 cycles of 94°C for 1 min, 55°C for 1 min, and
72°C for 1 min. The PCR products were analyzed by 2%
agarose gel electrophoresis to detect the 285-bp human
BMP-2 mRNA, 279-bp human BMP-7 mRNA, 546-bp rat
BMP-4 mRNA, and 682-bp G3PDH mRNA.
Radiographic analysis
Ten days after the gene transfer, the rats (each group N =
6) were sacrificed with an overdose of sodium pentobar-
bital. The injected regions of the calf muscles were excised
and analyzed with a soft X-ray to detect calcified areas
(SRO-M50, Saffron Inc., Tokyo, Japan).
Histological and immunohistochemical analyses
Specimens (each group N = 1) obtained 1, 3, 5, 7 and 10
days after electroporation were fixed with 0.05 M phos-
phate-buffered 4% paraformaldehyde (pH 7.4), embed-
ded in paraffin without decalcification, cut into 4-μm-
thick sections, and then stained with hematoxylin and
eosin (HE), and von Kossa stain. For immunohistochem-
ical detection of BMP-4, serial sections were rehydrated
and immersed in 0.5% periodic acid solution for 10 min
to eliminate the non-specific reaction by endogenous per-
oxidase, then incubated in PBS containing 10% bovine
serum albumin for 15 min, and washed with PBS. They
were then incubated with an anti-BMP-4 monoclonal
antibody (Novocastra laboratories, Newcastle, United
Kingdom) diluted 1:400. Antibody incubation was car-
ried out for 12 h at 4°C, and the sections were rinsed sev-
eral times before incubating them with peroxidase-
labelled secondary antibody (Sigma, St. Louis, USA)
diluted 1:200 for 1 h at room temperature. The incubation
was terminated by washing the sections with PBS. The sec-
tions were then immersed in a medium that consisted of
3, 3'– diaminobenzidine tetrahydrochloride (20 mg),
30% H2O2, (10 μl), and 0.05 M Tris-HCl buffer (pH 7.6)
(100 ml) for 10 min at room temperature.
Statistical analysis
Results are presented as the mean ± standard error of the
mean (SEM). The statistical analysis of differences in the
ALP activity among the groups was performed by analysis
of variance (ANOVA), followed by Fisher's comparison
test.
Results
ALP activity in C2C12 cells
Ten days after the gene transfer by lipofection, the C2C12
cells that had been directly and simultaneously trans-
fected with equal doses of pCAGGS-BMP-2 and pCAGGC-
BMP-7 showed stronger ALP activity by histochemistry
than cells transfected with the BMP-2 gene alone (Fig. 2A).
In contrast, almost no positive cells were seen in the
C2C12 cells transfected with pCAGGS-BMP-7 or pCAGGS
alone. Quantitative analysis of the ALP activity revealed
that the activity in the pCAGGS-BMP-2 and pCAGGS-
BMP-7-treated group was more than 5 times greater than
in the single-gene transfer or control groups (p < 0.05)
(Fig. 2B).
Human BMP-2 and BMP-7 mRNA expression in muscles 
electroporated with pCAGGS-BMP-2 and pCAGGS-BMP-
7
To evaluate whether the human BMP-2 and -7 genes could
be simultaneously and directly transferred by in vivo elec-
troporation, we analyzed the BMPs' mRNA expression in
the electroporated muscles by RT-PCR. The presence of
human BMP-2 or BMP-7 mRNAs transcribed from
pCAGGS-BMP-2 or pCAGGS-BMP-7 in the electroporated
muscles was detected 1,3,5,7 and 9 days after treatment
(Fig. 3). Both human BMP-2 and BMP-7 mRNAs were co-
expressed in muscles after the simultaneous transfer of
pCAGGS-BMP-2 and pCAGGS-BMP-7 using transcutane-
ous  in vivo electroporation up to 9 days. The G3PDH
mRNA control was detected in all groups. These data
revealed that multiple BMP genes could be successfully
transferred by in vivo electroporation.
Simultaneous and direct electroporation-mediated in vivo 
gene transfer of pCAGGS-BMP-2 and pCAGGS-BMP-7 BMC Musculoskeletal Disorders 2006, 7:62 http://www.biomedcentral.com/1471-2474/7/62
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Simultaneous gene transfer with BMP-2 and BMP-7 in vitro Figure 2
Simultaneous gene transfer with BMP-2 and BMP-7 in vitro. ALP activity in C2C12 cells transfected with pCAGGS, 
pCAGGS and pCAGGS-BMP-2, pCAGGS and pCAGGS-BMP-7, or pCAGGS-BMP-2 and pCAGGS-BMP-7. ALP staining in the 
C2C12 cells 10 days after the treatment (A). There were many more ALP-positive clusters in the combined (BMP-2 and BMP-
7) gene transfer group than in cultures transfected with either gene alone. Quantitative analysis of the ALP activity in C2C12 
cells transfected with BMP-2, BMP-7, or the combined BMP-2 and BMP-7 genes (B). A more than five-fold increase in ALP 
activity was seen after gene transfer with pCAGGS-BMP-2 and pCAGGS-BMP-7 compared with pCAGGS-BMP-7 or pCAGGS-
BMP-2 alone, respectively. (*P < 0.05.)BMC Musculoskeletal Disorders 2006, 7:62 http://www.biomedcentral.com/1471-2474/7/62
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induces more rapid ossification than the transfer of either 
gene alone
The induction of bone formation was investigated by radi-
ographic and histological observations 10 days after the
gene transfer.
Radiographic findings
Radiographs revealed opacities that had well-defined mar-
gins in the target muscles of groups receiving electropora-
tion with pCAGGS and pCAGGS-BMP-2, and pCAGGS-
BMP-2 and pCAGGS-BMP-7. The opaque areas in the
muscles treated simultaneously with the BMP-2 and BMP-
7 genes were larger and clearer than those in the other
group (Fig. 4). In contrast, we could not detect well-
defined opacities in muscles that received transferred
pCAGGS-BMP-7 and pCAGGs or pCAGGS alone.
Histological findings
We examined sections from muscles harvested 1, 3, 5, 7,
or 10 days after the electroporation histologically, by HE
and von Kossa staining. By 10 days after the treatment,
both cartilaginous tissues and bone had formed in speci-
mens treated with pCAGGS and pCAGGS-BMP-2 or
pCAGGS-BMP-2 and pCAGGS-BMP-7. However, in spec-
imens from rats that received pCAGGS-BMP-2, the carti-
laginous regions, rather than ossified regions, were
predominant and widely distributed. Partially calcified
areas were also observed by von Kossa stain (Fig. 5A,B). In
contrast, bone was frequently observed among muscle fib-
ers in the pCAGGS-BMP-2 and pCAGGS-BMP-7-treated
specimens (Fig. 5C), and the bone contained osteoblasts,
osteocytes, and osteoclasts. In addition, calcification was
further advanced in these pCAGGS-BMP-2 and pCAGGS-
BMP-7-treated specimens than in the pCAGGS-BMP-2-
treated specimens, as revealed by von Kossa stain (Fig.
5D). Neither cartilaginous tissue nor bone was observed
in the specimens treated with pCAGGS or pCAGGS and
pCAGGS-BMP-7, 10 days after treatment.
Expression of rat endogenous BMP-4 mRNA
In the group treated with the combined BMP-2 and BMP-
7 genes, rat BMP-4 mRNA was expressed, and its level
increased up to 3 days after gene transfer in a time-
dependent manner. Its expression gradually decreased
thereafter, and disappeared by 9 days after the gene trans-
fer (Fig. 6). Rat BMP-4 mRNA expression was weak in the
BMP-2 and in the BMP-7 single-gene transfer groups.
Immunohistochemical reactivity of BMP-4
The distribution of BMP-4-positive cells showed that,
compared with specimens treated with single-gene trans-
fer, there were higher numbers of positive cells in speci-
mens treated with both the BMP-2 and BMP-7 genes. The
BMP-4-positive cells were located in the matrix between
the muscle fibers, which was greatly expanded in these
specimens (Fig 7).
Discussion
In the present study, we evaluated the effect of the direct
and simultaneous gene transfer of human BMP-2 and
BMP-7 gene expression vectors (pCAGGS-BMP-2 and
pCAGGS-BMP-7) on osteoinduction using in vivo electro-
poration.
In vitro studies showed previously that BMP purified from
the conditioned medium of cultured CHO cells that were
transfected with equal amounts of BMP-2 and BMP-7
expression vectors increases the ALP activity of mouse
stromal cells far better than BMP purified from the
medium of cells transfected with one of these vectors
alone. These results suggest that a BMP-2/7 heterodimer
forms under these conditions and causes the high ALP
RT-PCR evaluation of BMP-2 and BMP-7 gene expression after simultaneous gene transfer into skeletal muscles Figure 3
RT-PCR evaluation of BMP-2 and BMP-7 gene expression after simultaneous gene transfer into skeletal mus-
cles. RT-PCR of human BMP-2 or BMP-7 mRNA in muscle after transfection by transcutaneous electroporation with pCAGGS 
and pCAGGS-BMP-2, pCAGGS and pCAGGS-BMP-7, or pCAGGS-BMP-2 and pCAGGS-BMP-7.BMC Musculoskeletal Disorders 2006, 7:62 http://www.biomedcentral.com/1471-2474/7/62
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activity, indicating that the BMP-2/7 heterodimer has a
strong bone-inducing activity [9,10,16]. Furthermore,
mixing the conditioned media from cells secreting either
BMP-2 or BMP-7 alone does not increase the ALP activity
synergistically [10,16]. These systems had three steps: the
first was the combined gene transfer of BMP-2 and BMP-7
into epithelial cells to produce BMP-2/7. Next the BMP2/
7 protein was purified from the supernatant of these cells.
Finally, the purified protein was added to the preosteob-
lastic or myoblastic cells. Here, we assessed the effect of
the direct and simultaneous gene transfer of BMP-2 and
BMP-7 into skeletal muscles. Before our in vivo study, we
carried out an in vitro experiment using the mouse myob-
lastic C2C12 cell line to determine whether cells directly
and simultaneously transfected with the BMP-2 and BMP-
7 genes would express these genes, as we hoped they
would  in vivo. In the present study, the C2C12 cells
showed higher ALP activity in the group receiving the
BMP-2 and BMP-7 genes than in the control group or the
groups transfected with a single BMP expression plasmid.
These results agreed with the previous studies [9,10].
Based on our in vitro study, we examined whether in vivo
electroporation with equal doses of pCAGGS-BMP-2 and
pCAGGS-BMP-7 is effective for bone formation. Ten days
after treatment, direct and simultaneous transfer of the
BMP-2 and BMP-7 genes induced higher ALP activity
(data not shown), and more intense calcification than did
the transfer of either gene alone. In contrast, the calcified
areas observed 10 days after the gene transfer with
pCAGGS-BMP-2 alone were mostly cartilaginous tissue
with very little bone. The muscles transfected with
pCAGGS-BMP-7 did not form cartilaginous tissue, bone,
or calcified areas during the observation period. There-
fore, this study strongly suggests that the direct and simul-
taneous gene transfer of equal doses of pCAGGS-BMP-2
and pCAGGS-BMP-7 into skeletal muscles by in vivo elec-
troporation was successful and resulted in greater osteoin-
ductive activity than the direct transfer of either gene
alone. This effect may be owing to the formation of the
BMP-2/7 heterodimer as suggested for the in vitro studies
[9,10,16]. However, to fully understand our results, we
may need to consider the more complicated and dynamic
events underlying osteoinduction in vivo, because the
extracellular matrix components that bind to BMPs [17]
and/or the different affinities of the BMPs for their recep-
tors [18-21] must be involved in the osteoinductive activ-
ity. Further study is needed to clarify the mechanism of
the osteoinduction reported here. For example, a single
vector that can express BMP-2 and BMP-7 simultaneously
might be useful for assessing the influence of the BMP-2/
7 heterodimer on osteoinductive activity in vivo.
Endogenous BMP-4 mRNA was highly expressed in the
skeletal muscle of rats receiving the pCAGGS-BMP-2 and
pCAGGS-BMP-7 genes, but its expression was much
weaker in the skeletal muscles of rats receiving only one of
the genes. It is reported that BMP-7 down-regulates BMP-
4 mRNA through the stages of proliferation, matrix forma-
tion, and mineralization in long-term primary cultures of
fetal rat calvarial (FRC) cells [14]. In C2C12 cells, BMP-7
up-regulates the BMP-4 mRNA [22]. On the other hand,
BMP-2 inhibits BMP-4 mRNA expression initially, but
stimulates it during the mineralization phase [11,13]. In
the costochondral growth-plate chondrocytes, BMP-2
induces the expression of BMP-4 mRNA in a cell matura-
Soft X – ray analysis 10 days after in vivo electroporation Figure 4
Soft X – ray analysis 10 days after in vivo electropora-
tion. Soft X-ray images of target muscles on day 10 after 
gene transfer with pCAGGS and pCAGGS-BMP-2, pCAGGS 
and pCAGGS-BMP-7, or pCAGGS-BMP-2 and pCAGGS-
BMP-7. Radio-opaque areas were seen after electroporation 
with pCAGGS and pCAGGS-BMP-2 (arrow) or pCAGGS-
BMP-2 and pCAGGS-BMP-7 (arrow). No opacities with well-
defined margins were detected in muscles that received 
pCAGGS and pCAGGS-BMP-7 by electroporation. Scale bar: 
10 mm.BMC Musculoskeletal Disorders 2006, 7:62 http://www.biomedcentral.com/1471-2474/7/62
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tion-dependent manner [12]. However, this is the first
report that the simultaneous gene transfer by in vivo elec-
troporation of BMP-2 and BMP-7 increases the level of
BMP-4 mRNA.
Under conditions of normal osteoblastic cell differentia-
tion, rat BMP-4 mRNA is expressed in the early phase with
peak expression levels during the proliferation and matrix
formation phases, but it declines afterwards in FRC cells
[10,23]. In vivo, a transient elevation in the BMP-4 mRNA
levels is reported in osteoprogenitor cells of the perios-
teum in the early stages of fracture repair [24-27]. Moreo-
ver, BMP-4 mRNA is detected in areas where fibroblast-
like cells and preosteoblasts migrate, in the early stage of
distraction osteogenesis [28]. These results seem to sug-
gest that BMP-4 plays an important role in the early phase
of osteoinduction. Our histological results at 3 and 5 days,
during the early phase of the BMP-4 mRNA increase,
revealed abundant migratory spindle-shaped cells, i.e.,
fibroblast-like cells. These cells were in the same location
as those that stained positive for BMP-4 by immunohisto-
chemistry. Therefore, the expression of BMP-4 mRNA and
its increase in the early phase might be involved with the
effective bone formation seen when the BMP-2 and BMP-
7 genes were simultaneously transferred into rat skeletal
muscles by transcutaneous in vivo electroporation.
Histological analyses 10 days after in vivo electroporation Figure 5
Histological analyses 10 days after in vivo electroporation. Histological examinations were carried out 10 days after 
electroporation with pCAGGS and pCAGGS-BMP-2 or pCAGGS-BMP-2 and pCAGGS-BMP-7. A section stained with HE 
from muscle electroporated with pCAGGS and pCAGGS-BMP-2 (A) contained cartilage (arrow). A serial section stained with 
von Kossa showing partially calcified areas (B, arrows). A HE-stained section of muscle electroporated with pCAGGS-BMP-2 
and pCAGGS-BMP-7 showing ectopic bone (C, arrows). The calcified areas that stained with von Kossa (D, arrows) in the 
pCAGGS-BMP-2 and pCAGGS-BMP-7-transfected muscles were much wider and more strongly stained than in the BMP-2-
transfected sections (B). Scale bar: 100 μm.BMC Musculoskeletal Disorders 2006, 7:62 http://www.biomedcentral.com/1471-2474/7/62
Page 9 of 11
(page number not for citation purposes)
In this study, we used an animal model to study ectopic
bone formation in the skeletal muscles to examine the
efficiency of simultaneous and direct BMP-2 and BMP-7
gene transfer using in vivo electroporation. For clinical
applications, it may be possible to reconstruct bone and
the accompanying muscle in jaw areas that have been
damaged, for example, by trauma or tumour treatment.
Moreover, BMP-2 and BMP-7 gene transfer into the perio-
stea to augment the alveolar ridge or fracture repair may
enhance periosteal cell differentiation efficiently, because
it is well known that periostea have multi-potential stem
cells [29-31]. If successful, such clinical applications
would be very significant and wide-ranging, and could
include fracture repair, orthognathic surgery, alveolar
ridge augmentation, and dental implants.
Conclusion
We propose that the direct and simultaneous gene transfer
of BMP-2 and BMP-7 by in vivo electroporation is more
effective than the transfer of BMP-2 alone, which we
explored in an earlier paper using the same conditions,
such as the dose of plasmid and the size of the electrodes
[5]. Since the major drawbacks of using adenovirus vec-
tors, i.e., the need for titration, the potential toxicity, and
Immunohistochemical analysis of BMP-4 in skeletal muscle Figure 7
Immunohistochemical analysis of BMP-4 in skeletal muscle. Immunohistochemical detection of BMP-4-positive cells 5 
days after the combined transfer of the BMP-2 and BMP-7 genes (a), or the BMP-2 gene alone (b). The positive cells (arrows) 
were numerous in the matrix between the muscle fibres in the muscle transfected with the combined BMP genes compared 
with muscle transfected with BMP-2 alone.
Rat BMP-4 expression after gene transfer with BMP-2, BMP-7, or BMP-2 and BMP-7 Figure 6
Rat BMP-4 expression after gene transfer with BMP-2, BMP-7, or BMP-2 and BMP-7. Rat BMP-4 mRNA expression 
in muscles electroporated with pCAGGS-BMP-2, pCAGGS-BMP-7, or pCAGGS-BMP-2 and pCAGGS-BMP-7 detected by RT-
PCR. The BMP-4 mRNA was highly expressed in the muscles that received the combined BMP-2 and BMP-7 gene transfer.BMC Musculoskeletal Disorders 2006, 7:62 http://www.biomedcentral.com/1471-2474/7/62
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the need to suppress the host immune response, are not
necessary using this system, gene therapy via in vivo elec-
troporation is safer and simpler than via viral vectors. As a
methodological consideration, electroporation is quite
suitable for the direct and simultaneous transfer of two or
more BMP genes for bone regeneration therapy.
Competing interests
The author(s) declare that they have no competing inter-
ests.
Authors' contributions
MK performed all experiments, analyzed the data, and
prepared the manuscript. KB and TY contributed to the in
vivo electroporation experiments and provided useful dis-
cussions about the results. HM and JM provided signifi-
cant help to MK in constructing the plasmid vector.
Acknowledgements
This work was supported in part by a Grant-in-Aid for scientific research 
from Okayama University and a Grant-in-Aid for young investigators (B) 
17791301 from the Japanese Ministry of Education, Culture, Sports, Science 
and Technology.
References
1. Ferber D, Marshall E: Gene therapy: safer and virus-free?  Science
2001, 294:1638-1642.
2. Nishikawa M, Huang L: Nonviral vectors in the new millennium:
delivery barriers in gene transfer.  Hum Gene Ther 2001,
12:861-870.
3. Aihara H, Miyazaki J: Gene transfer into muscle by electropora-
tion in vivo.  Nature Biotechnol 1998, 16:867-870.
4. Maruyama H, Sugawa M, Moriguchi Y, Imazaki I, Ishikawa Y, Ataka K,
Hasegawa S, Ito Y, Higuchi N, Kazama J, Gejyo F, Miyazaki J: Contin-
uous erythropoietin delivery by muscle-targeted gene trans-
fer using in vivo electroporation.  Hum Gene Ther 2000,
11:429-437.
5. Kawai M, Bessho K, Kaihara S, Sonobe J, Oda K, Iizuka T, Maruyama
H: Ectopic bone formation by bone morphogenetic protein-
2 gene transfer to skeletal muscle using transcutaneous in
vivo electroporation.  Hum Gene Ther 2003, 14:1547-1556.
6. Wolf H, Rols MP, Boldt E, Meumann E, Teissie J: Control by pulse
parameters of electric field-mediated gene transfer in mam-
malian cells.  Biophys J 1994, 66:524-531.
7. Cehng H, Jiang W, Phillips FM, Haydon RC, Peng Y, Zhou L, Luu HH,
An N, Breyer B, Vanicharn P, Szatkowski JP, Park JY, He TC: Osteo-
genic activity of the fourteen types of human bone morpho-
genetic proteins (BMPs).  J Bone Joint Surg Am 2003, 85:1544-1552.
8. Li JZ, Li H, Sasaki T, Holman D, Beres B, Dumont RJ, Pittman DD,
Hankins GR, Helm GA: Osteogenic potential of five different
recombinant human bone morphogenetic protein adenovi-
ral vectors in the rat.  Gene Ther 2003, 10:1735-1743.
9. Zhu W, Rawlins BA, Boachie-Adjei O, Myers ER, Arimizu J, Choi E,
Lieberman JR, Crystal RG, Hidaka C: Combined bone morphoge-
netic protein-2 and -7 gene transfer enhances osteoblastic
differentiation and spine fusion in a rodent model.  J Bone
Miner Res 2004, 19:2021-2032.
10. Israel DI, Nove J, Kerns KM, Kaufman RJ, Rosen V, Cox KA, Wozney
JM:  Heterodimeric bone morphogenetic proteins show
enhanced activities in vitro and in vivo.  Growth Factors 1996,
13:291-300.
11. Chen D, Harris MA, Rossini G, Dunstan CR, Dallas SL, Feng JQ,
Mundy GR, Harris SE: Bone morphogenetic protein 2 (BMP-2)
enhances BMP-3, BMP-4, and bone cell differentiation
marker gene expression during the induction of mineralized
bone matrix formation in cultures of fetal rat calvarial oste-
oblasts.  Calcif Tissue Intl 1997, 60:283-290.
12. Erickson DM, Harris SE, Dean DD, Harris MA, Wozney JM, Boyan
BD, Schwartz Z: Recombinant bone morphogenetic protein
(BMP)-2 regulates costochondral growth plate chondrocytes
and induces expression of BMP-2 and BMP-4 in a cell matu-
ration-dependent manner.  J Orthop Res 1997, 15:371-380.
13. Hino J, Matsuo H, Kangawa K: Bone morphogenetic protein-3b
(BMP-3b) gene expression is correlated with differentiation
in rat calvarial osteoblasts.  Biochem Biophys Res Commun 1999,
256:419-424.
14. Yeh LC, Unda R, Lee JC: Osteogenic protein-1 differentially reg-
ulates the mRNA expression of bone morphogenetic and
their receptors in primary cultures of osteoblasts.  J Cell Physiol
2000, 185:87-97.
15. Niwa H, Yamamura K, Miyazaki J: Efficient selection for high-
expression transfectants with a novel eukaryotic vector.
Gene 1991, 108:193-199.
16. Hazama M, Aono A, Ueno N: Efficient expression of het-
erodimer of bone morphogenetic protein.  Biochem Biophys Res
Commun 1995, 209:859-866.
17. Reddy AH, Cunningham NS: Initiation and promotion of bone
differentiation by bone morphogenetic proteins.  J Bone Miner
Res 1993, 8:499-502.
18. Dijke TP, Yamashita H, Sampath TK, Reddy AH, Estevez M, Riddle
DL, Ichijyo H, Heldin CH, Miyazono K: Identification of type I
receptors for osteogenic protein-1 and bone morphogenetic
protein-4.  J Biol Chem 1994, 269:16985-16988.
19. Rosenzweig BL, Lmamura T, Okadome T, Cox GN, Yamashita H,
Dijke TP, Helden CH, Miyazono K: Cloning and characterization
of a human type II receptor for bone morphogenetic pro-
teins.  Proc Natl Acad Sci U S A 1995, 92:7632-7636.
20. Nishitoh H, Ichijo H, Kimura M, Matsumoto T, Makishima F,
Yamaguchi A, Yamashita H, Enomoto S, Miyazono K: Identification
of type I and Type II serine/threonine kinase receptors for
growth/differentiation factor-5.  J Biol Chem 1996,
271:21345-21352.
21. Hoffmann A, Gross G: BMP signaling pathways in cartilage and
bone formation.  Crit Rev Eukaryot Gene Expr Rev 2001, 11:23-45.
22. Yeh LC, Tsai AD, Lee JC: Osteogenic protein-1 (BMP-7) induces
osteoblastic cell differentiation of the pluripotent mesenchy-
mal cell line C2C12.  J Cell Biochem 2002, 87:292-304.
23. Harris SE, Sabatini M, Harris MA, Feng JQ, Wozney JM, Mundy GR:
Expression of bone morphogenetic protein messenger RNA
in prolonged cultures of fetal rat calvarial cells.  J Bone Miner
Res 1994, 9:389-394.
24. Nakase T, Nomura S, Yoshikawa H, Hashimoto J, Kitamura Y, Oikawa
S, Yakaoka K: Transient and localized expression of bone mor-
phogenetic protein 4 messenger RNA during fracture heal-
ing.  J Bone Miner Res 1994, 9:651-659.
25. Onishi T, Ishidou Y, Nagamine T, Yone K, Imamura T, Kato M, Sam-
path TK, Ten DP, Sakou T: Distinct and overlapping patterns of
localization of bone morphogenetic protein (BMP) family
members and a BMP type II receptor during fracture healing
in rats.  Bone 1998, 22:605-612.
26. Yaoita H, Orimo H, Shirai Y, Shimada T: Expression of bone mor-
phogenetic proteins and rat distal-less homolog genes fol-
lowing rat femoral fracture.  J Bone Miner Res 2000, 18:63-70.
27. Yoshimura Y, Nomura S, Kawasaki S, Tsutsumimoto T, Shimizu T,
Takaoka K: Colocalization of noggin and bone morphogenetic
protein-4 during fracture healing.  J Bone Miner Res 2001,
16:876-884.
28. Berven LG, Simpson H, Triffitt JT: Expression of BMP-4 mRNA
during distraction osteogenesis in rabbits.  Acta Orthop Scand
1998, 69:420-425.
29. Zhang X, Xie C, Lin AS, Ito H, Awad H, Lieberman JR, Rubery PT,
Schwarz EM, O'Keefe RJ, Guldberg RE: Periosteal progenitor cell
fate in segmental cortical bone graft transplantations+ impli-
cations for functional tissue engineering.  J bone Mine Res 2005,
20:2124-2137.
30. Park J, Gelse K, Frank S, von der Mark K, Aigner T, Schneider H:
Transgene-activated mesenchymal cells for articular carti-
lage repair: a comparison of primary bone marrow-, peri-
chondrium/S periosteum- and fat-derived cells.  J Gene Med
2006, 8:112-125.
31. De Bari C, Dell' Acco F, Vanlauwe J, Eyckmans J, Khan IM, Archer
CW, Jones EA, McGonagle D, Mitsiadis TA, Pitzalis C, Luyten FP:
Mesenchymal multipotency of adult human periosteal cellsPublish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Musculoskeletal Disorders 2006, 7:62 http://www.biomedcentral.com/1471-2474/7/62
Page 11 of 11
(page number not for citation purposes)
demonstrated by single-cell lineage analysis.  Arthritis Rhuem
2006, 54:1209-1221.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-2474/7/62/prepub